A Study to Evaluate Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of ASC47 in Combination With Semaglutide
Clinical trial NCT06972992 · COMPLETED
Trial details
- NCT number
- NCT06972992
- Sponsor
- Ascletis Pharma (China) Co., Limited
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2025-04-18
- Primary completion
- 2025-09-22
- Enrollment
- 28
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.